Literature DB >> 29753111

IRAK2 counterbalances oncogenic Smurf1 in colon cancer cells by dictating ER stress.

Jingwen Liu1, Yuhan Chen2, Qingyang Huang3, Wen Liu4, Xiqing Ji5, Fan Hu6, Ying Zhu7, Lingqiang Zhang8, Guanglong Dong9.   

Abstract

The endoplasmic reticulum (ER) is a cellular organelle with central roles in maintaining proteostasis. The accumulation of misfolded proteins in the ER lumen causes ER stress. Cells evoke an evolutionarily conserved adaptive signaling network "unfolded protein response" to restore ER homeostasis, however, how the signaling network is delicately orchestrated remains largely unrevealed. Meanwhile, the HECT type E3 ligase Smad ubiquitylation regulatory factor 1 (Smurf1) has been reported to play critical roles in several important biological pathways by targeting distinct substrates for ubiquitylation, including WFS1, a critical mediator of ER stress, whereas the regulation of Smurf1 activity and abundance upon ER stress are poorly understood. Here, we identified Interleukin-1 Receptor Associated Kinase 2 (IRAK2) as a novel modulator of Smurf1 in response to ER stress induced cell death. Mechanistically, IRAK2 phosphorylates Smurf1 at threonine residues to promote its self-degradation by ubiquitylation, resulting in altered cascade of ER effectors to induce apoptosis. Reduced IRAK2 expression correlates with increased Smurf1 abundance in human colorectal cancer cells. Taken together, these findings demonstrate a novel mechanism of interplays for the different branches of ER stress signaling network and highlight IRAK2 as a potential tumor suppressor to counterbalance oncogenic Smurf1.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colon cancer; ER stress; IRAK2; Phosphorylation; Smurf1; Ubiquitylation

Mesh:

Substances:

Year:  2018        PMID: 29753111     DOI: 10.1016/j.cellsig.2018.05.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  New Clues to Prognostic Biomarkers of Four Hematological Malignancies.

Authors:  Samson Pandam Salifu; Albert Doughan
Journal:  J Cancer       Date:  2022-05-09       Impact factor: 4.478

2.  TSPYL5 activates endoplasmic reticulum stress to inhibit cell proliferation, migration and invasion in colorectal cancer.

Authors:  Chao Huang; Chunping He; Peng Ruan; Rui Zhou
Journal:  Oncol Rep       Date:  2020-06-09       Impact factor: 3.906

Review 3.  Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer.

Authors:  Longtao Yang; Wenwen Zhou; Hui Lin
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

Review 4.  IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.

Authors:  Joshua Bennett; Daniel T Starczynowski
Journal:  Curr Opin Hematol       Date:  2022-01-01       Impact factor: 3.284

5.  Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma.

Authors:  Jing Li; Yuchen Sun; Yuan Ma; Xu Zhao; Xuanzi Sun; Yuzhu Wang; Xiaozhi Zhang
Journal:  J Oncol       Date:  2022-02-15       Impact factor: 4.375

Review 6.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

7.  lncRNA NEAT1 mediates sepsis progression by regulating Irak2 via sponging miR-370-3p.

Authors:  Ting Xiao; Chuihua Sun; Ying Xiao; Yunbao Li
Journal:  Biol Open       Date:  2020-06-24       Impact factor: 2.422

8.  Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses.

Authors:  Guillaume N Fiches; Dawei Zhou; Weili Kong; Ayan Biswas; Elshafa H Ahmed; Robert A Baiocchi; Jian Zhu; Netty Santoso
Journal:  PLoS Pathog       Date:  2020-08-25       Impact factor: 7.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.